nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP2B6—Ifosfamide—testicular cancer	0.122	0.185	CbGbCtD
Modafinil—CYP3A5—Ifosfamide—testicular cancer	0.0965	0.146	CbGbCtD
Modafinil—CYP2C19—Ifosfamide—testicular cancer	0.0778	0.118	CbGbCtD
Modafinil—CYP2C9—Ifosfamide—testicular cancer	0.0647	0.0979	CbGbCtD
Modafinil—CYP2B6—Cisplatin—testicular cancer	0.0596	0.0902	CbGbCtD
Modafinil—ADRA1B—vas deferens—testicular cancer	0.0538	0.917	CbGeAlD
Modafinil—CYP3A5—Etoposide—testicular cancer	0.0461	0.0698	CbGbCtD
Modafinil—CYP2B6—Doxorubicin—testicular cancer	0.0399	0.0604	CbGbCtD
Modafinil—CYP3A4—Ifosfamide—testicular cancer	0.0376	0.0569	CbGbCtD
Modafinil—CYP1A2—Etoposide—testicular cancer	0.0343	0.0519	CbGbCtD
Modafinil—CYP2C9—Cisplatin—testicular cancer	0.0315	0.0476	CbGbCtD
Modafinil—CYP3A4—Vinblastine—testicular cancer	0.02	0.0302	CbGbCtD
Modafinil—CYP3A4—Etoposide—testicular cancer	0.018	0.0272	CbGbCtD
Modafinil—CYP3A4—Doxorubicin—testicular cancer	0.0123	0.0186	CbGbCtD
Modafinil—SLC6A3—testis—testicular cancer	0.00158	0.027	CbGeAlD
Modafinil—CYP2B6—gonad—testicular cancer	0.00131	0.0223	CbGeAlD
Modafinil—CYP3A5—female gonad—testicular cancer	0.00107	0.0182	CbGeAlD
Modafinil—CYP2B6—testis—testicular cancer	0.000942	0.0161	CbGeAlD
Modafinil—Hyperglycaemia—Doxorubicin—testicular cancer	0.000244	0.000867	CcSEcCtD
Modafinil—Nausea—Dactinomycin—testicular cancer	0.000243	0.000865	CcSEcCtD
Modafinil—Agranulocytosis—Epirubicin—testicular cancer	0.000243	0.000864	CcSEcCtD
Modafinil—Pneumonia—Doxorubicin—testicular cancer	0.000242	0.000862	CcSEcCtD
Modafinil—Gastrointestinal pain—Etoposide—testicular cancer	0.000242	0.000862	CcSEcCtD
Modafinil—Drowsiness—Doxorubicin—testicular cancer	0.000241	0.000857	CcSEcCtD
Modafinil—Visual impairment—Methotrexate—testicular cancer	0.00024	0.000856	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000239	0.00085	CcSEcCtD
Modafinil—Vomiting—Ifosfamide—testicular cancer	0.000238	0.000848	CcSEcCtD
Modafinil—Hypersensitivity—Cisplatin—testicular cancer	0.000238	0.000848	CcSEcCtD
Modafinil—Bradycardia—Epirubicin—testicular cancer	0.000238	0.000847	CcSEcCtD
Modafinil—Rash—Ifosfamide—testicular cancer	0.000236	0.000841	CcSEcCtD
Modafinil—Dermatitis—Ifosfamide—testicular cancer	0.000236	0.000841	CcSEcCtD
Modafinil—Erythema multiforme—Methotrexate—testicular cancer	0.000236	0.00084	CcSEcCtD
Modafinil—Urticaria—Etoposide—testicular cancer	0.000235	0.000837	CcSEcCtD
Modafinil—Stomatitis—Doxorubicin—testicular cancer	0.000235	0.000835	CcSEcCtD
Modafinil—Rhinitis—Epirubicin—testicular cancer	0.000234	0.000834	CcSEcCtD
Modafinil—Abdominal pain—Etoposide—testicular cancer	0.000234	0.000833	CcSEcCtD
Modafinil—Body temperature increased—Etoposide—testicular cancer	0.000234	0.000833	CcSEcCtD
Modafinil—Conjunctivitis—Doxorubicin—testicular cancer	0.000234	0.000833	CcSEcCtD
Modafinil—Urinary tract infection—Doxorubicin—testicular cancer	0.000234	0.000833	CcSEcCtD
Modafinil—Asthenia—Cisplatin—testicular cancer	0.000232	0.000825	CcSEcCtD
Modafinil—Pharyngitis—Epirubicin—testicular cancer	0.000232	0.000825	CcSEcCtD
Modafinil—Cardiac disorder—Methotrexate—testicular cancer	0.000232	0.000825	CcSEcCtD
Modafinil—Sweating—Doxorubicin—testicular cancer	0.000231	0.000822	CcSEcCtD
Modafinil—Urinary tract disorder—Epirubicin—testicular cancer	0.000231	0.000821	CcSEcCtD
Modafinil—Oedema peripheral—Epirubicin—testicular cancer	0.00023	0.000819	CcSEcCtD
Modafinil—Haematuria—Doxorubicin—testicular cancer	0.00023	0.000817	CcSEcCtD
Modafinil—Connective tissue disorder—Epirubicin—testicular cancer	0.000229	0.000817	CcSEcCtD
Modafinil—Urethral disorder—Epirubicin—testicular cancer	0.000229	0.000815	CcSEcCtD
Modafinil—Epistaxis—Doxorubicin—testicular cancer	0.000227	0.000808	CcSEcCtD
Modafinil—Angiopathy—Methotrexate—testicular cancer	0.000226	0.000806	CcSEcCtD
Modafinil—Sinusitis—Doxorubicin—testicular cancer	0.000226	0.000804	CcSEcCtD
Modafinil—Immune system disorder—Methotrexate—testicular cancer	0.000225	0.000803	CcSEcCtD
Modafinil—Visual impairment—Epirubicin—testicular cancer	0.000225	0.000801	CcSEcCtD
Modafinil—Mediastinal disorder—Methotrexate—testicular cancer	0.000225	0.000801	CcSEcCtD
Modafinil—Agranulocytosis—Doxorubicin—testicular cancer	0.000225	0.0008	CcSEcCtD
Modafinil—Chills—Methotrexate—testicular cancer	0.000224	0.000797	CcSEcCtD
Modafinil—Nausea—Ifosfamide—testicular cancer	0.000223	0.000793	CcSEcCtD
Modafinil—Diarrhoea—Cisplatin—testicular cancer	0.000221	0.000787	CcSEcCtD
Modafinil—Erythema multiforme—Epirubicin—testicular cancer	0.000221	0.000786	CcSEcCtD
Modafinil—Bradycardia—Doxorubicin—testicular cancer	0.00022	0.000783	CcSEcCtD
Modafinil—Mental disorder—Methotrexate—testicular cancer	0.000219	0.000778	CcSEcCtD
Modafinil—Hypersensitivity—Etoposide—testicular cancer	0.000218	0.000776	CcSEcCtD
Modafinil—Malnutrition—Methotrexate—testicular cancer	0.000217	0.000774	CcSEcCtD
Modafinil—Cardiac disorder—Epirubicin—testicular cancer	0.000217	0.000772	CcSEcCtD
Modafinil—Rhinitis—Doxorubicin—testicular cancer	0.000217	0.000771	CcSEcCtD
Modafinil—Pharyngitis—Doxorubicin—testicular cancer	0.000214	0.000764	CcSEcCtD
Modafinil—Urinary tract disorder—Doxorubicin—testicular cancer	0.000213	0.00076	CcSEcCtD
Modafinil—Oedema peripheral—Doxorubicin—testicular cancer	0.000213	0.000758	CcSEcCtD
Modafinil—Dysgeusia—Methotrexate—testicular cancer	0.000213	0.000757	CcSEcCtD
Modafinil—Asthenia—Etoposide—testicular cancer	0.000212	0.000756	CcSEcCtD
Modafinil—Connective tissue disorder—Doxorubicin—testicular cancer	0.000212	0.000756	CcSEcCtD
Modafinil—Angiopathy—Epirubicin—testicular cancer	0.000212	0.000754	CcSEcCtD
Modafinil—Urethral disorder—Doxorubicin—testicular cancer	0.000212	0.000754	CcSEcCtD
Modafinil—Immune system disorder—Epirubicin—testicular cancer	0.000211	0.000751	CcSEcCtD
Modafinil—Mediastinal disorder—Epirubicin—testicular cancer	0.00021	0.000749	CcSEcCtD
Modafinil—Back pain—Methotrexate—testicular cancer	0.00021	0.000748	CcSEcCtD
Modafinil—Chills—Epirubicin—testicular cancer	0.00021	0.000746	CcSEcCtD
Modafinil—Pruritus—Etoposide—testicular cancer	0.000209	0.000746	CcSEcCtD
Modafinil—Arrhythmia—Epirubicin—testicular cancer	0.000209	0.000743	CcSEcCtD
Modafinil—Visual impairment—Doxorubicin—testicular cancer	0.000208	0.000741	CcSEcCtD
Modafinil—Vomiting—Cisplatin—testicular cancer	0.000205	0.000731	CcSEcCtD
Modafinil—Mental disorder—Epirubicin—testicular cancer	0.000205	0.000729	CcSEcCtD
Modafinil—Erythema multiforme—Doxorubicin—testicular cancer	0.000204	0.000727	CcSEcCtD
Modafinil—Rash—Cisplatin—testicular cancer	0.000204	0.000725	CcSEcCtD
Modafinil—Dermatitis—Cisplatin—testicular cancer	0.000204	0.000725	CcSEcCtD
Modafinil—Malnutrition—Epirubicin—testicular cancer	0.000203	0.000724	CcSEcCtD
Modafinil—Diarrhoea—Etoposide—testicular cancer	0.000203	0.000721	CcSEcCtD
Modafinil—Ill-defined disorder—Methotrexate—testicular cancer	0.000202	0.000718	CcSEcCtD
Modafinil—Anaemia—Methotrexate—testicular cancer	0.000201	0.000715	CcSEcCtD
Modafinil—Cardiac disorder—Doxorubicin—testicular cancer	0.000201	0.000714	CcSEcCtD
Modafinil—Flatulence—Epirubicin—testicular cancer	0.0002	0.000713	CcSEcCtD
Modafinil—Tension—Epirubicin—testicular cancer	0.000199	0.00071	CcSEcCtD
Modafinil—Dysgeusia—Epirubicin—testicular cancer	0.000199	0.000709	CcSEcCtD
Modafinil—Nervousness—Epirubicin—testicular cancer	0.000197	0.000703	CcSEcCtD
Modafinil—Back pain—Epirubicin—testicular cancer	0.000197	0.0007	CcSEcCtD
Modafinil—Angiopathy—Doxorubicin—testicular cancer	0.000196	0.000698	CcSEcCtD
Modafinil—Malaise—Methotrexate—testicular cancer	0.000196	0.000698	CcSEcCtD
Modafinil—Dizziness—Etoposide—testicular cancer	0.000196	0.000697	CcSEcCtD
Modafinil—Muscle spasms—Epirubicin—testicular cancer	0.000195	0.000696	CcSEcCtD
Modafinil—Immune system disorder—Doxorubicin—testicular cancer	0.000195	0.000695	CcSEcCtD
Modafinil—Vertigo—Methotrexate—testicular cancer	0.000195	0.000695	CcSEcCtD
Modafinil—Mediastinal disorder—Doxorubicin—testicular cancer	0.000195	0.000693	CcSEcCtD
Modafinil—Chills—Doxorubicin—testicular cancer	0.000194	0.00069	CcSEcCtD
Modafinil—Arrhythmia—Doxorubicin—testicular cancer	0.000193	0.000687	CcSEcCtD
Modafinil—Nausea—Cisplatin—testicular cancer	0.000192	0.000683	CcSEcCtD
Modafinil—Cough—Methotrexate—testicular cancer	0.00019	0.000675	CcSEcCtD
Modafinil—Mental disorder—Doxorubicin—testicular cancer	0.000189	0.000674	CcSEcCtD
Modafinil—Ill-defined disorder—Epirubicin—testicular cancer	0.000189	0.000672	CcSEcCtD
Modafinil—Convulsion—Methotrexate—testicular cancer	0.000188	0.00067	CcSEcCtD
Modafinil—Vomiting—Etoposide—testicular cancer	0.000188	0.00067	CcSEcCtD
Modafinil—Malnutrition—Doxorubicin—testicular cancer	0.000188	0.00067	CcSEcCtD
Modafinil—Anaemia—Epirubicin—testicular cancer	0.000188	0.000669	CcSEcCtD
Modafinil—Agitation—Epirubicin—testicular cancer	0.000187	0.000665	CcSEcCtD
Modafinil—Rash—Etoposide—testicular cancer	0.000187	0.000665	CcSEcCtD
Modafinil—Dermatitis—Etoposide—testicular cancer	0.000186	0.000664	CcSEcCtD
Modafinil—Headache—Etoposide—testicular cancer	0.000185	0.00066	CcSEcCtD
Modafinil—Flatulence—Doxorubicin—testicular cancer	0.000185	0.00066	CcSEcCtD
Modafinil—Chest pain—Methotrexate—testicular cancer	0.000185	0.000659	CcSEcCtD
Modafinil—Arthralgia—Methotrexate—testicular cancer	0.000185	0.000659	CcSEcCtD
Modafinil—Myalgia—Methotrexate—testicular cancer	0.000185	0.000659	CcSEcCtD
Modafinil—Tension—Doxorubicin—testicular cancer	0.000185	0.000657	CcSEcCtD
Modafinil—Dysgeusia—Doxorubicin—testicular cancer	0.000184	0.000656	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000184	0.000654	CcSEcCtD
Modafinil—Malaise—Epirubicin—testicular cancer	0.000183	0.000653	CcSEcCtD
Modafinil—Discomfort—Methotrexate—testicular cancer	0.000183	0.000651	CcSEcCtD
Modafinil—Nervousness—Doxorubicin—testicular cancer	0.000183	0.000651	CcSEcCtD
Modafinil—Vertigo—Epirubicin—testicular cancer	0.000183	0.00065	CcSEcCtD
Modafinil—Syncope—Epirubicin—testicular cancer	0.000182	0.000649	CcSEcCtD
Modafinil—Back pain—Doxorubicin—testicular cancer	0.000182	0.000648	CcSEcCtD
Modafinil—Muscle spasms—Doxorubicin—testicular cancer	0.000181	0.000644	CcSEcCtD
Modafinil—Palpitations—Epirubicin—testicular cancer	0.00018	0.00064	CcSEcCtD
Modafinil—Confusional state—Methotrexate—testicular cancer	0.000179	0.000637	CcSEcCtD
Modafinil—Loss of consciousness—Epirubicin—testicular cancer	0.000179	0.000636	CcSEcCtD
Modafinil—Cough—Epirubicin—testicular cancer	0.000177	0.000632	CcSEcCtD
Modafinil—Anaphylactic shock—Methotrexate—testicular cancer	0.000177	0.000631	CcSEcCtD
Modafinil—Convulsion—Epirubicin—testicular cancer	0.000176	0.000627	CcSEcCtD
Modafinil—Infection—Methotrexate—testicular cancer	0.000176	0.000627	CcSEcCtD
Modafinil—Nausea—Etoposide—testicular cancer	0.000176	0.000626	CcSEcCtD
Modafinil—Hypertension—Epirubicin—testicular cancer	0.000176	0.000625	CcSEcCtD
Modafinil—Ill-defined disorder—Doxorubicin—testicular cancer	0.000175	0.000621	CcSEcCtD
Modafinil—Nervous system disorder—Methotrexate—testicular cancer	0.000174	0.000619	CcSEcCtD
Modafinil—Anaemia—Doxorubicin—testicular cancer	0.000174	0.000619	CcSEcCtD
Modafinil—Chest pain—Epirubicin—testicular cancer	0.000173	0.000616	CcSEcCtD
Modafinil—Arthralgia—Epirubicin—testicular cancer	0.000173	0.000616	CcSEcCtD
Modafinil—Myalgia—Epirubicin—testicular cancer	0.000173	0.000616	CcSEcCtD
Modafinil—Agitation—Doxorubicin—testicular cancer	0.000173	0.000616	CcSEcCtD
Modafinil—Anxiety—Epirubicin—testicular cancer	0.000172	0.000614	CcSEcCtD
Modafinil—Skin disorder—Methotrexate—testicular cancer	0.000172	0.000613	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000172	0.000612	CcSEcCtD
Modafinil—Hyperhidrosis—Methotrexate—testicular cancer	0.000171	0.00061	CcSEcCtD
Modafinil—Discomfort—Epirubicin—testicular cancer	0.000171	0.000609	CcSEcCtD
Modafinil—Malaise—Doxorubicin—testicular cancer	0.00017	0.000604	CcSEcCtD
Modafinil—Dry mouth—Epirubicin—testicular cancer	0.000169	0.000603	CcSEcCtD
Modafinil—Vertigo—Doxorubicin—testicular cancer	0.000169	0.000602	CcSEcCtD
Modafinil—Anorexia—Methotrexate—testicular cancer	0.000169	0.000602	CcSEcCtD
Modafinil—Syncope—Doxorubicin—testicular cancer	0.000169	0.000601	CcSEcCtD
Modafinil—Confusional state—Epirubicin—testicular cancer	0.000167	0.000596	CcSEcCtD
Modafinil—Palpitations—Doxorubicin—testicular cancer	0.000166	0.000592	CcSEcCtD
Modafinil—Anaphylactic shock—Epirubicin—testicular cancer	0.000166	0.000591	CcSEcCtD
Modafinil—Oedema—Epirubicin—testicular cancer	0.000166	0.000591	CcSEcCtD
Modafinil—Hypotension—Methotrexate—testicular cancer	0.000166	0.00059	CcSEcCtD
Modafinil—Loss of consciousness—Doxorubicin—testicular cancer	0.000165	0.000589	CcSEcCtD
Modafinil—Infection—Epirubicin—testicular cancer	0.000165	0.000587	CcSEcCtD
Modafinil—Cough—Doxorubicin—testicular cancer	0.000164	0.000584	CcSEcCtD
Modafinil—Shock—Epirubicin—testicular cancer	0.000163	0.000581	CcSEcCtD
Modafinil—Convulsion—Doxorubicin—testicular cancer	0.000163	0.00058	CcSEcCtD
Modafinil—Nervous system disorder—Epirubicin—testicular cancer	0.000163	0.000579	CcSEcCtD
Modafinil—Hypertension—Doxorubicin—testicular cancer	0.000162	0.000578	CcSEcCtD
Modafinil—Tachycardia—Epirubicin—testicular cancer	0.000162	0.000577	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000162	0.000575	CcSEcCtD
Modafinil—Skin disorder—Epirubicin—testicular cancer	0.000161	0.000574	CcSEcCtD
Modafinil—Hyperhidrosis—Epirubicin—testicular cancer	0.00016	0.000571	CcSEcCtD
Modafinil—Insomnia—Methotrexate—testicular cancer	0.00016	0.000571	CcSEcCtD
Modafinil—Chest pain—Doxorubicin—testicular cancer	0.00016	0.00057	CcSEcCtD
Modafinil—Myalgia—Doxorubicin—testicular cancer	0.00016	0.00057	CcSEcCtD
Modafinil—Arthralgia—Doxorubicin—testicular cancer	0.00016	0.00057	CcSEcCtD
Modafinil—Anxiety—Doxorubicin—testicular cancer	0.00016	0.000568	CcSEcCtD
Modafinil—Paraesthesia—Methotrexate—testicular cancer	0.000159	0.000567	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000159	0.000566	CcSEcCtD
Modafinil—Discomfort—Doxorubicin—testicular cancer	0.000158	0.000563	CcSEcCtD
Modafinil—Anorexia—Epirubicin—testicular cancer	0.000158	0.000563	CcSEcCtD
Modafinil—Dyspnoea—Methotrexate—testicular cancer	0.000158	0.000563	CcSEcCtD
Modafinil—Somnolence—Methotrexate—testicular cancer	0.000158	0.000561	CcSEcCtD
Modafinil—Dry mouth—Doxorubicin—testicular cancer	0.000157	0.000558	CcSEcCtD
Modafinil—Dyspepsia—Methotrexate—testicular cancer	0.000156	0.000556	CcSEcCtD
Modafinil—Hypotension—Epirubicin—testicular cancer	0.000155	0.000552	CcSEcCtD
Modafinil—Confusional state—Doxorubicin—testicular cancer	0.000155	0.000551	CcSEcCtD
Modafinil—Decreased appetite—Methotrexate—testicular cancer	0.000154	0.000549	CcSEcCtD
Modafinil—Oedema—Doxorubicin—testicular cancer	0.000154	0.000547	CcSEcCtD
Modafinil—Anaphylactic shock—Doxorubicin—testicular cancer	0.000154	0.000547	CcSEcCtD
Modafinil—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000153	0.000545	CcSEcCtD
Modafinil—Fatigue—Methotrexate—testicular cancer	0.000153	0.000544	CcSEcCtD
Modafinil—Infection—Doxorubicin—testicular cancer	0.000153	0.000543	CcSEcCtD
Modafinil—Pain—Methotrexate—testicular cancer	0.000152	0.00054	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000151	0.000538	CcSEcCtD
Modafinil—Shock—Doxorubicin—testicular cancer	0.000151	0.000538	CcSEcCtD
Modafinil—Nervous system disorder—Doxorubicin—testicular cancer	0.000151	0.000536	CcSEcCtD
Modafinil—Insomnia—Epirubicin—testicular cancer	0.00015	0.000534	CcSEcCtD
Modafinil—Tachycardia—Doxorubicin—testicular cancer	0.00015	0.000534	CcSEcCtD
Modafinil—Skin disorder—Doxorubicin—testicular cancer	0.000149	0.000531	CcSEcCtD
Modafinil—Paraesthesia—Epirubicin—testicular cancer	0.000149	0.00053	CcSEcCtD
Modafinil—Hyperhidrosis—Doxorubicin—testicular cancer	0.000148	0.000528	CcSEcCtD
Modafinil—Dyspnoea—Epirubicin—testicular cancer	0.000148	0.000527	CcSEcCtD
Modafinil—Somnolence—Epirubicin—testicular cancer	0.000148	0.000525	CcSEcCtD
Modafinil—Anorexia—Doxorubicin—testicular cancer	0.000146	0.000521	CcSEcCtD
Modafinil—Feeling abnormal—Methotrexate—testicular cancer	0.000146	0.00052	CcSEcCtD
Modafinil—Dyspepsia—Epirubicin—testicular cancer	0.000146	0.00052	CcSEcCtD
Modafinil—Gastrointestinal pain—Methotrexate—testicular cancer	0.000145	0.000516	CcSEcCtD
Modafinil—Decreased appetite—Epirubicin—testicular cancer	0.000144	0.000514	CcSEcCtD
Modafinil—Hypotension—Doxorubicin—testicular cancer	0.000143	0.000511	CcSEcCtD
Modafinil—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000143	0.00051	CcSEcCtD
Modafinil—Fatigue—Epirubicin—testicular cancer	0.000143	0.000509	CcSEcCtD
Modafinil—Constipation—Epirubicin—testicular cancer	0.000142	0.000505	CcSEcCtD
Modafinil—Pain—Epirubicin—testicular cancer	0.000142	0.000505	CcSEcCtD
Modafinil—Urticaria—Methotrexate—testicular cancer	0.000141	0.000502	CcSEcCtD
Modafinil—Abdominal pain—Methotrexate—testicular cancer	0.00014	0.000499	CcSEcCtD
Modafinil—Body temperature increased—Methotrexate—testicular cancer	0.00014	0.000499	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00014	0.000498	CcSEcCtD
Modafinil—Insomnia—Doxorubicin—testicular cancer	0.000139	0.000494	CcSEcCtD
Modafinil—Paraesthesia—Doxorubicin—testicular cancer	0.000138	0.000491	CcSEcCtD
Modafinil—Dyspnoea—Doxorubicin—testicular cancer	0.000137	0.000487	CcSEcCtD
Modafinil—Feeling abnormal—Epirubicin—testicular cancer	0.000137	0.000487	CcSEcCtD
Modafinil—Somnolence—Doxorubicin—testicular cancer	0.000136	0.000486	CcSEcCtD
Modafinil—Gastrointestinal pain—Epirubicin—testicular cancer	0.000136	0.000483	CcSEcCtD
Modafinil—Dyspepsia—Doxorubicin—testicular cancer	0.000135	0.000481	CcSEcCtD
Modafinil—Decreased appetite—Doxorubicin—testicular cancer	0.000133	0.000475	CcSEcCtD
Modafinil—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000133	0.000472	CcSEcCtD
Modafinil—Fatigue—Doxorubicin—testicular cancer	0.000132	0.000471	CcSEcCtD
Modafinil—Urticaria—Epirubicin—testicular cancer	0.000132	0.000469	CcSEcCtD
Modafinil—Pain—Doxorubicin—testicular cancer	0.000131	0.000467	CcSEcCtD
Modafinil—Constipation—Doxorubicin—testicular cancer	0.000131	0.000467	CcSEcCtD
Modafinil—Abdominal pain—Epirubicin—testicular cancer	0.000131	0.000467	CcSEcCtD
Modafinil—Body temperature increased—Epirubicin—testicular cancer	0.000131	0.000467	CcSEcCtD
Modafinil—Hypersensitivity—Methotrexate—testicular cancer	0.000131	0.000465	CcSEcCtD
Modafinil—Asthenia—Methotrexate—testicular cancer	0.000127	0.000453	CcSEcCtD
Modafinil—Feeling abnormal—Doxorubicin—testicular cancer	0.000127	0.00045	CcSEcCtD
Modafinil—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000126	0.000447	CcSEcCtD
Modafinil—Pruritus—Methotrexate—testicular cancer	0.000125	0.000447	CcSEcCtD
Modafinil—Hypersensitivity—Epirubicin—testicular cancer	0.000122	0.000435	CcSEcCtD
Modafinil—Urticaria—Doxorubicin—testicular cancer	0.000122	0.000434	CcSEcCtD
Modafinil—Abdominal pain—Doxorubicin—testicular cancer	0.000121	0.000432	CcSEcCtD
Modafinil—Body temperature increased—Doxorubicin—testicular cancer	0.000121	0.000432	CcSEcCtD
Modafinil—Diarrhoea—Methotrexate—testicular cancer	0.000121	0.000432	CcSEcCtD
Modafinil—Asthenia—Epirubicin—testicular cancer	0.000119	0.000424	CcSEcCtD
Modafinil—Pruritus—Epirubicin—testicular cancer	0.000117	0.000418	CcSEcCtD
Modafinil—Dizziness—Methotrexate—testicular cancer	0.000117	0.000417	CcSEcCtD
Modafinil—Diarrhoea—Epirubicin—testicular cancer	0.000114	0.000404	CcSEcCtD
Modafinil—Hypersensitivity—Doxorubicin—testicular cancer	0.000113	0.000403	CcSEcCtD
Modafinil—Vomiting—Methotrexate—testicular cancer	0.000113	0.000401	CcSEcCtD
Modafinil—Rash—Methotrexate—testicular cancer	0.000112	0.000398	CcSEcCtD
Modafinil—Dermatitis—Methotrexate—testicular cancer	0.000112	0.000398	CcSEcCtD
Modafinil—Headache—Methotrexate—testicular cancer	0.000111	0.000395	CcSEcCtD
Modafinil—Asthenia—Doxorubicin—testicular cancer	0.00011	0.000392	CcSEcCtD
Modafinil—Dizziness—Epirubicin—testicular cancer	0.00011	0.000391	CcSEcCtD
Modafinil—Pruritus—Doxorubicin—testicular cancer	0.000109	0.000387	CcSEcCtD
Modafinil—Vomiting—Epirubicin—testicular cancer	0.000105	0.000376	CcSEcCtD
Modafinil—Nausea—Methotrexate—testicular cancer	0.000105	0.000375	CcSEcCtD
Modafinil—Diarrhoea—Doxorubicin—testicular cancer	0.000105	0.000374	CcSEcCtD
Modafinil—Rash—Epirubicin—testicular cancer	0.000105	0.000372	CcSEcCtD
Modafinil—Dermatitis—Epirubicin—testicular cancer	0.000105	0.000372	CcSEcCtD
Modafinil—Headache—Epirubicin—testicular cancer	0.000104	0.00037	CcSEcCtD
Modafinil—Dizziness—Doxorubicin—testicular cancer	0.000102	0.000361	CcSEcCtD
Modafinil—Nausea—Epirubicin—testicular cancer	9.86e-05	0.000351	CcSEcCtD
Modafinil—Vomiting—Doxorubicin—testicular cancer	9.76e-05	0.000348	CcSEcCtD
Modafinil—Rash—Doxorubicin—testicular cancer	9.68e-05	0.000345	CcSEcCtD
Modafinil—Dermatitis—Doxorubicin—testicular cancer	9.67e-05	0.000344	CcSEcCtD
Modafinil—Headache—Doxorubicin—testicular cancer	9.62e-05	0.000342	CcSEcCtD
Modafinil—Nausea—Doxorubicin—testicular cancer	9.12e-05	0.000325	CcSEcCtD
